Ear Infection in Children: Antibiotics vs Watch & Wait
TL;DR
- Most ear infections (acute otitis media) in children over 2 years old with mild symptoms can be safely observed for 48–72 hours without antibiotics — this is called watchful waiting.
- When antibiotics are needed, high-dose amoxicillin (80–90 mg/kg/day) is the first-line choice per AAP guidelines.
- Immediate antibiotics are recommended for children under 6 months, children with severe symptoms (fever ≥39°C, moderate-to-severe ear pain), or bilateral infection in children under 2 years.
- If symptoms worsen or fail to improve within 48–72 hours, reassess — a switch to amoxicillin-clavulanate or an alternative agent may be warranted.
- Antibiotic overuse drives resistance; appropriate use protects both your child and the community.
Acute otitis media (AOM) — the clinical term for a middle ear infection — is one of the most common reasons parents bring a child to the doctor and one of the leading reasons ear infection antibiotics children when needed becomes a pressing question in the exam room. It is also one of the most common reasons antibiotics are prescribed in pediatric primary care. Yet not every ear infection demands an antibiotic prescription. International guidelines from the American Academy of Pediatrics (AAP) and the UK's National Institute for Health and Care Excellence (NICE) now support a more nuanced approach: immediate treatment for those who clearly need it, and a period of observation — watchful waiting — for those who may recover without drugs.
This article explains the evidence behind both strategies, outlines when antibiotics are truly necessary, provides weight-based dosing guidance for first- and second-line agents, and covers the practical details every caregiver should know.
What Is Acute Otitis Media and Why Are Children So Vulnerable?
Acute otitis media is a bacterial or viral infection of the middle ear space — the air-filled cavity behind the tympanic membrane (eardrum). It is defined by the rapid onset of signs and symptoms of middle ear inflammation: ear pain (otalgia), bulging of the tympanic membrane, and often fever.
Epidemiology
AOM is overwhelmingly a disease of early childhood:
- By age 3, approximately 80% of children will have had at least one episode.
- Peak incidence occurs between 6 and 24 months of age.
- Recurrent AOM (three or more episodes in 6 months, or four or more in 12 months) affects roughly 10–20% of children.
Why children?
The eustachian tube in young children is shorter, more horizontal, and more compliant than in adults. This anatomy impairs drainage of the middle ear and makes it easier for nasopharyngeal bacteria to ascend into the middle ear space. Immature immune function and frequent viral upper respiratory infections further increase susceptibility.
Common pathogens
The three predominant bacterial causes of AOM are:
- Streptococcus pneumoniae (~25–50% of cases)
- Non-typeable Haemophilus influenzae (~15–30%)
- Moraxella catarrhalis (~3–20%)
A significant proportion of AOM episodes — estimates range from 15 to 40% — involve viral pathogens alone or viral-bacterial co-infection. This mixed etiology is one reason not every episode requires antibiotics.
Watchful Waiting: What the Evidence Says
The concept of watchful waiting (also termed "observation" or "delayed prescribing") is not negligence — it is a guideline-endorsed strategy based on high-quality evidence showing that many children with uncomplicated AOM improve spontaneously.
Key trials
Two landmark randomized controlled trials published in the New England Journal of Medicine in 2011 — one by Hoberman et al. and one by Tähtinen et al. — examined immediate amoxicillin-clavulanate versus placebo in children under 2 years with stringently diagnosed AOM. Both trials found that antibiotics shortened symptom duration and reduced treatment failure rates, but the absolute benefit was modest: roughly 1 in 5 to 1 in 7 children benefited beyond what would have occurred with supportive care alone (number needed to treat [NNT] of approximately 5–7 for clinical cure by day 7).
A Cochrane systematic review (Venekamp et al., 2015) pooled data from 13 trials and concluded:
- Antibiotics had no effect on pain at 24 hours.
- At 2–7 days, antibiotics reduced pain in a relatively small proportion (NNT ~16 in high-income populations).
- Antibiotics reduced the risk of tympanic membrane perforation and contralateral AOM.
- Adverse effects — primarily diarrhea, rash, and vomiting — were more common in children given antibiotics (number needed to harm [NNH] ~14).
These findings support the position that watchful waiting is safe and reasonable for carefully selected children, while also confirming that antibiotics offer a real, measurable advantage in more severe or high-risk presentations.
AAP and NICE Guidelines: Who Gets Antibiotics Immediately?
Both major guidelines use an age- and severity-stratified approach. The table below summarizes the AAP 2013 clinical practice guideline (the most recent comprehensive AOM guideline from the AAP) and the NICE NG91 antimicrobial prescribing guideline.
Comparison Table: Immediate Antibiotics vs Watchful Waiting
| Criterion | Immediate Antibiotics | Watchful Waiting Appropriate |
|---|---|---|
| Age < 6 months | Yes — treat all | Not recommended |
| Age 6–23 months, bilateral AOM | Yes — treat | Not recommended |
| Age 6–23 months, unilateral AOM, severe symptoms | Yes — treat | Not recommended |
| Age 6–23 months, unilateral AOM, non-severe | Either option acceptable | Yes — with safety-net prescription |
| Age ≥ 2 years, severe symptoms | Yes — treat | Not recommended |
| Age ≥ 2 years, non-severe, unilateral | Either option acceptable | Yes — preferred by many guidelines |
| Age ≥ 2 years, non-severe, bilateral | Either option acceptable | Yes — with safety-net prescription |
| Otorrhea (drainage through TM or tube) | Yes — treat | Not recommended |
| Recurrent AOM (≥3 in 6 months) | Consider treatment | Discuss with clinician |
Severe symptoms are defined by the AAP as: moderate-to-severe otalgia, otalgia lasting ≥48 hours, or temperature ≥39°C (102.2°F).
NICE NG91 takes a slightly more conservative antibiotic approach, generally favoring a "no antibiotic" or "back-up (delayed) antibiotic" strategy for most children over 2 years with uncomplicated AOM, and recommending immediate antibiotics primarily for systemically unwell children, children under 2 with bilateral AOM, and children with otorrhea.
How watchful waiting works in practice
When a clinician opts for watchful waiting, the caregiver is given:
- Pain management instructions — regular acetaminophen (paracetamol) or ibuprofen at appropriate doses.
- A safety-net antibiotic prescription (in many settings) — to be filled only if symptoms worsen or do not improve within 48–72 hours.
- Clear return-to-care criteria — high fever, worsening pain, new discharge from the ear, lethargy, or signs of complications.
This approach reduces unnecessary antibiotic exposure by roughly 60–80% in studies of delayed prescribing, while maintaining parental confidence and safety.
First-Line Antibiotic: Amoxicillin Dosing
When an antibiotic is indicated, amoxicillin remains the unambiguous first-line agent. It has a favorable safety profile, a narrow spectrum relative to alternatives, good middle ear penetration, and activity against the most common AOM pathogen (S. pneumoniae).
Why "high-dose"?
Standard-dose amoxicillin (40–45 mg/kg/day) achieves middle ear fluid concentrations sufficient to kill susceptible S. pneumoniae. However, the prevalence of intermediate-resistance pneumococci (with penicillin MICs of 1–2 µg/mL) has increased worldwide. High-dose amoxicillin (80–90 mg/kg/day) achieves higher middle ear drug levels that exceed these intermediate MIC thresholds, improving bacteriological cure without requiring a broader-spectrum agent.
This high-dose approach is recommended as standard first-line therapy by both the AAP and multiple international guidelines.
Dosing Table: Antibiotic Regimens for AOM in Children
| Agent | Dose | Route | Frequency | Duration | When to Use |
|---|---|---|---|---|---|
| Amoxicillin | 80–90 mg/kg/day (max 3 g/day) | Oral | Divided q12h (BID) | 10 days (age <2 yr); 7 days (age 2–5 yr); 5–7 days (age ≥6 yr) | First-line for uncomplicated AOM |
| Amoxicillin-clavulanate (high-dose formulation) | 90 mg/kg/day of amoxicillin component (max 3 g/day amoxicillin) | Oral | Divided q12h (BID) | 10 days (age <2 yr); 7 days (age ≥2 yr) | Treatment failure at 48–72 h; recent amoxicillin use (within 30 days); concurrent purulent conjunctivitis |
| Cefdinir | 14 mg/kg/day (max 600 mg/day) | Oral | Once daily or divided BID | 5–10 days | Non-type I penicillin allergy |
| Ceftriaxone | 50 mg/kg IM (max 1 g) | IM injection | Once daily × 1–3 doses | 1–3 days | Vomiting/unable to tolerate oral; second-line failure |
| Azithromycin | 10 mg/kg day 1, then 5 mg/kg days 2–5 (max 500/250 mg) | Oral | Once daily | 5 days | Type I (anaphylactic) penicillin allergy only |
Notes on the table:
- Amoxicillin-clavulanate: Use the 14:1 or 7:1 formulation (e.g., Augmentin ES-600) to deliver 90 mg/kg/day amoxicillin without excessive clavulanate (which increases GI side effects). Standard 4:1 formulations given at high-dose amoxicillin levels would deliver too much clavulanate.
- Duration of therapy: The AAP guideline notes that shorter courses (7 days in children ≥2, 5–7 days in children ≥6) are reasonable for uncomplicated AOM in older children. Children under 2 years and those with severe symptoms should receive a full 10-day course.
- Azithromycin: Activity against S. pneumoniae is limited due to rising macrolide resistance (~30–40% in many regions). Reserve for true penicillin allergy (type I hypersensitivity with anaphylaxis, urticaria, or angioedema). Mild rash with amoxicillin is generally not a contraindication to cephalosporin use.
Treatment Failure: When to Change Course
Treatment failure is defined as persistent or worsening symptoms — persistent fever, ongoing significant ear pain, or new-onset otorrhea — after 48–72 hours of an appropriate antibiotic at the correct dose.
Step-up approach
- If initially on amoxicillin → switch to high-dose amoxicillin-clavulanate (targets beta-lactamase–producing H. influenzae and M. catarrhalis).
- If initially on amoxicillin-clavulanate → consider ceftriaxone IM for 3 days, or tympanocentesis with culture to guide therapy.
- If initially on watchful waiting → start amoxicillin at the standard high dose.
Tympanocentesis — needle aspiration of middle ear fluid — is both diagnostic and therapeutic. It is generally performed by an otolaryngologist and is recommended when a child fails two courses of appropriate antibiotics, or when an unusual or resistant organism is suspected.
When to suspect complications
True complications of AOM are rare in high-income settings but can be serious:
- Acute mastoiditis — tenderness and swelling behind the ear (over the mastoid bone), protrusion of the auricle.
- Intracranial complications — meningitis, epidural or brain abscess, lateral sinus thrombosis. Signs include severe headache, persistent high fever, altered mental status, focal neurological signs.
- Facial nerve palsy — rare but requires urgent evaluation.
Side Effects and Monitoring
Antibiotics are not benign. Caregivers should be informed of expected side effects and advised on when to seek reassessment.
Common side effects of amoxicillin
- Diarrhea (~10–25% of children on amoxicillin; higher with amoxicillin-clavulanate, up to 20–30%).
- Rash — a non-allergic maculopapular (flat, red) rash occurs in about 5–10% of courses. It is more common with concurrent viral infection (particularly Epstein-Barr virus). This is distinct from urticaria (hives), which may indicate a true allergy.
- Nausea/vomiting — generally mild.
- Candidal diaper dermatitis — yeast overgrowth due to alteration of normal flora.
Monitoring during treatment
- Reassess at 48–72 hours if symptoms are not improving.
- Complete the full prescribed course to reduce the risk of treatment failure and resistance, though emerging evidence suggests shorter courses are non-inferior in older children with uncomplicated AOM.
- No routine follow-up otoscopy is required for uncomplicated AOM with clinical resolution, per AAP guidance. However, follow-up is appropriate for recurrent AOM or persistent middle ear effusion lasting >3 months.
Contraindications and Special Considerations
| Scenario | Recommendation |
|---|---|
| True penicillin allergy (type I — anaphylaxis, angioedema, urticaria) | Avoid amoxicillin and amoxicillin-clavulanate. Use azithromycin or clindamycin. Cross-reactivity with cephalosporins is low (~1–2%) but caution warranted. |
| Non-severe penicillin allergy (mild rash only) | Cephalosporins (cefdinir, cefuroxime, ceftriaxone) are generally safe. |
| Recent amoxicillin use (within 30 days) | Start with amoxicillin-clavulanate rather than amoxicillin alone (higher likelihood of beta-lactamase–producing organisms). |
| Concurrent purulent conjunctivitis | Suggests H. influenzae etiology. Start with amoxicillin-clavulanate. |
| Tympanostomy tubes in place with AOM (otorrhea through tube) | Topical fluoroquinolone ear drops (ciprofloxacin/dexamethasone) are preferred over systemic antibiotics per AAP guidance. |
| Immunocompromised child | Lower threshold for immediate antibiotics and specialist referral. |
Special Populations
Neonates (< 1 month)
AOM in the neonatal period is uncommon but carries a higher risk of serious bacterial infection. Neonates with suspected AOM should be evaluated for sepsis and managed in consultation with a pediatric infectious disease specialist. Empiric therapy may differ from standard AOM treatment.
Children with recurrent AOM
For children meeting criteria for recurrent AOM (≥3 episodes in 6 months, or ≥4 in 12 months with ≥1 in the preceding 6 months):
- Prophylactic antibiotics are generally not recommended — the modest reduction in episodes does not outweigh the risk of promoting resistance and adverse effects.
- Tympanostomy tube placement should be discussed with an otolaryngologist for children with recurrent AOM and persistent middle ear effusion.
- Pneumococcal and influenza vaccination — ensure the child is up to date. PCV13 (or PCV15/PCV20 where available) has significantly reduced pneumococcal AOM.
Children with Down syndrome or craniofacial abnormalities
These children have anatomical variations in the eustachian tube and are at higher risk for AOM and chronic otitis media with effusion. A lower threshold for ENT referral and audiological assessment is appropriate.
Red Flags — When to Seek Immediate Medical Attention
Take your child to a doctor or emergency department immediately if any of the following occur:
- Temperature ≥40°C (104°F) or persistent fever despite appropriate antipyretics
- Swelling, redness, or tenderness behind the ear (possible mastoiditis)
- The child is lethargic, inconsolable, or difficult to arouse
- Stiff neck, severe headache, or light sensitivity (possible meningitis)
- Facial drooping or asymmetry (possible facial nerve involvement)
- Bloody or purulent discharge from the ear that does not improve within 48 hours of treatment
- The child appears dehydrated (reduced urine output, dry mouth, no tears)
- Symptoms worsen despite 48–72 hours of appropriate antibiotic therapy
- Any child under 3 months of age with fever and suspected ear infection
These signs may indicate a complication requiring urgent evaluation and potentially intravenous antibiotics or surgical intervention.
Frequently Asked Questions
1. Can my child's ear infection go away without antibiotics?
Yes. A substantial proportion of AOM episodes — particularly in children over 2 years with unilateral, non-severe disease — resolve spontaneously. The Cochrane review data suggest that roughly 80% of children with uncomplicated AOM will improve within a few days without antibiotics. However, this does not mean all children should go untreated. The decision depends on the child's age, symptom severity, and whether infection is unilateral or bilateral.
2. How do I manage my child's pain while waiting?
Pain management is essential, whether or not antibiotics are prescribed. Acetaminophen (paracetamol) at 15 mg/kg every 4–6 hours or ibuprofen at 10 mg/kg every 6–8 hours (for children ≥6 months) are the recommended first-line analgesics. Topical anesthetic ear drops (benzocaine-containing solutions) may provide additional short-term relief but should not be used if the tympanic membrane is perforated or if tubes are present.
3. Is amoxicillin safe for babies?
Amoxicillin has been extensively studied and used in infants and is one of the safest antibiotics in pediatric practice. It is approved for use from birth. The most common adverse effects are mild — diarrhea and rash. Serious allergic reactions are rare but possible. Dosing is weight-based, and caregivers should use an oral syringe for accurate measurement.
4. My child got a rash on amoxicillin — are they allergic?
Not necessarily. A flat, non-itchy, maculopapular rash is common during amoxicillin therapy and is usually not a true allergy — it is often related to the underlying viral illness. True allergic reactions involve hives (raised, itchy welts), facial swelling, or difficulty breathing. If you are uncertain, consult your child's pediatrician. Formal allergy testing (penicillin skin testing) can help clarify whether future penicillin use is safe.
5. Why does the doctor want to "wait and see" instead of prescribing right away?
Because evidence shows that many ear infections clear on their own, and every antibiotic course carries risks: diarrhea, allergic reactions, yeast infections, and — critically — contributing to antibiotic resistance. By carefully selecting which children receive antibiotics, clinicians reduce unnecessary drug exposure while still treating those who genuinely benefit. You will typically be given a "safety-net" prescription to fill if symptoms worsen.
6. How do I know if the antibiotic is working?
You should see meaningful improvement in pain and fever within 48–72 hours of starting the antibiotic. The child need not be completely symptom-free at this point, but there should be a clear trend toward improvement. If symptoms plateau or worsen after 48–72 hours, contact your prescriber — a change in antibiotic may be needed.
7. Should I give my child probiotics during antibiotic treatment?
Some evidence suggests that certain probiotic strains (e.g., Lactobacillus rhamnosus GG, Saccharomyces boulardii) may modestly reduce antibiotic-associated diarrhea in children. The AAP does not make a strong recommendation for or against probiotics in this setting. If you choose to use them, administer them at least 2 hours apart from the antibiotic dose.
8. Can ear infections cause hearing loss?
Temporary, mild conductive hearing loss during and shortly after AOM is very common and typically resolves as the middle ear fluid clears — this may take several weeks. Persistent middle ear effusion lasting more than 3 months warrants audiology evaluation, particularly in children at risk for speech and language delay. Permanent hearing loss from AOM is rare in high-income settings but remains a concern in areas with limited access to care.
References
-
Lieberthal AS, Carroll AE, Chonmaitree T, et al. The Diagnosis and Management of Acute Otitis Media. Pediatrics. 2013;131(3):e964-e999. PMID: 23439909
-
NICE. Otitis media (acute): antimicrobial prescribing. Guideline NG91. 2018. nice.org.uk/guidance/ng91
-
Venekamp RP, Sanders SL, Steyerberg EW, et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015;(6):CD000219. PMID: 26099233
-
Hoberman A, Paradise JL, Rockette HE, et al. Treatment of Acute Otitis Media in Children under 2 Years of Age. N Engl J Med. 2011;364(2):105-115. PMID: 21226577
-
Tähtinen PA, Laine MK, Huovinen P, et al. A Placebo-Controlled Trial of Antimicrobial Treatment for Acute Otitis Media. N Engl J Med. 2011;364(2):116-126. PMID: 21226578
-
Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngol Head Neck Surg. 2016;154(1 Suppl):S1-S41. PMID: 26832942
-
FDA. Prescribing Information: Amoxicillin Capsules, Tablets, and Powder for Oral Suspension. DailyMed/NLM
-
Marchisio P, Chonmaitree T, Leibovitz E, et al. Panel 7 — Treatment and Comparative Effectiveness Research. Otolaryngol Head Neck Surg. 2020;162(1 Suppl):S87-S106. PMID: 31910063
-
Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics. 2017;140(3):e20170181. PMID: 28784702
About the Author
Dr. Stanislav Ozarchuk, PharmD, is a clinical pharmacist with over 15 years of experience in evidence-based pharmacotherapy, medication safety, and patient education. He has worked across hospital, community, and academic pharmacy settings, with particular expertise in pediatric and antimicrobial pharmacotherapy. Dr. Ozarchuk writes for PillsCard.com to help patients and caregivers make informed decisions about medications based on current clinical evidence and international guidelines.
Medical Disclaimer
This article is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. The information presented here reflects published clinical guidelines and peer-reviewed evidence available at the time of writing but should not replace the professional judgment of a qualified healthcare provider. Always consult your child's pediatrician or prescribing clinician before starting, stopping, or changing any medication. Individual clinical circumstances, local resistance patterns, and patient-specific factors may affect treatment decisions. If your child is experiencing a medical emergency, contact your local emergency services immediately.